- Q4 2023 Prothena Corporation PLC Earnings Call TranscriptFeb 15, 2024$28.52 (+4.51%)Earnings
- Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Prothena Corporation PLC at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Prothena Corporation PLC at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Prothena Corporation PLC at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Prothena Corporation PLC Earnings Call TranscriptFeb 23, 2023$50.9 (-2.30%)Earnings
- Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Prothena Corporation PLC at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Prothena Corporation PLC at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Q4 2021 Prothena Corporation PLC Earnings Call TranscriptFeb 17, 2022$35.06 (-5.90%)Earnings
- Prothena Corporation PLC at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Prothena Corporation PLC at Citi BioPharma Conference (Virtual) - Fireside Chat TranscriptSep 08, 2021
- Prothena Corporation PLC at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Prothena Corporation PLC to Review Oral Presentations from AD/PD 2021 TranscriptMar 11, 2021
- Q4 2020 Prothena Corporation PLC Earnings Call TranscriptFeb 11, 2021$15.7 (-0.19%)Earnings
- Prothena Corporation PLC to Discuss AFFIRM-AL Study - Conference Call TranscriptFeb 02, 2021
- Prothena Corporation PLC - PRX004 Phase 1 Study Results TranscriptDec 09, 2020
- Prothena Corporation PLC to Discuss Results from Part 1 of the Phase 2 PASADENA Study - Conference Call TranscriptSep 15, 2020
- Q4 2019 Prothena Corporation PLC Earnings Call TranscriptFeb 12, 2020$13.51 (+4.49%)Earnings
- Prothena Corporation PLC to Discuss Results of the Phase 3 VITAL Amyloidosis Study - Conference Call TranscriptApr 18, 2019
- Prothena Corporation PLC at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Prothena Corporation PLC Earnings Call TranscriptFeb 14, 2019$12.75Earnings
Q4 2018 Prothena Corporation PLC Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Prothena Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded.
I would now like to turn the conference over to your host, Ms. Ellen Rose. Ma'am, you may begin.
Thank you, Valerie. Good afternoon, everyone, and welcome to Prothena's investor conference call to review our fourth quarter and full year 2018 financial results and business progress as well as our 2019 financial guidance. Please review the press release we issued earlier today, which is available at our website at prothena.com and is also attached to a Form 8-K filed today with the SEC.
Speaking on today's call to discuss our 2018 pipeline programs and corporate activities we have Dr. Gene Kinney, our President and Chief Executive Officer; Dr. Radhika Tripuraneni, our Chief Development Officer; and Dr. Wagner Zago, our Chief Scientific Officer. In addition, Tran Nguyen, our Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)